Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Carlsbad, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...

Cyrex Array 2 Provides Canadian Clinicians Cutting-Edge Technology for Accurate Assessment and Monitoring of Intestinal Barrier Function PHOENIX, AZ--(Marketwired - July 13, 2016) - Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability...

Cyrex Array 2 Provides Clinicians Cutting-Edge Technology for Accurate Assessment and Monitoring of Intestinal Barrier Function PHOENIX, AZ--(Marketwired - July 13, 2016) - Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability...